NCT02671006
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
- Locations
-
- Chu Saint Etienne Saint-Etienne, France
Clinical trial condition
Urticaria
Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.
93 public trials
7 recruiting studies
Urticaria trial results
NCT02576041
- Conditions
- Allergic Rhinitis, Hypersensitivity, Hypersensitivity, Immediate, +11 more
- Locations
-
- Azienda Ospedaliero-Universitaria Policlinico Modena, Italy
NCT02866864
- Conditions
- Asthma, Bronchial Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
- Locations
-
- Gachon University Gil Medical Center Incheon, South Korea
Completed
Validation of an Urticaria Control Test
NCT01614834
- Conditions
- Chronic Disease, Chronic Urticaria, Disease Attributes, +9 more
- Locations
-
- Universitätshautklinik Mainz Mainz, Rhineland-Palatinate, Germany
- Allergie-Centrum-Charite Berlin, State of Berlin, Germany
Completed
Development of an Urticaria Control Test
NCT01610128
- Conditions
- Chronic Disease, Chronic Urticaria, Disease Attributes, +9 more
- Locations
-
- Universitätshautklinik Mainz Mainz, Rhineland-Palatinate, Germany
- Allergie-Centrum-Charite Berlin, State of Berlin, Germany
NCT01715740
- Conditions
- Chronic Disease, Chronic Urticaria, Disease Attributes, +9 more
- Locations
-
- Chang Gung Memorial Hospital Taoyuan, Taiwan
Completed
A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria
NCT01987947
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
- Locations
-
- Toronto, Ontario, Canada
- Berlin, Germany
- Mainz, Germany
NCT00886795
- Conditions
- Exanthema, Hypersensitivity, Hypersensitivity, Immediate, +9 more
- Locations
-
- Johns Hopkins Arthritis Center Baltimore, Maryland, United States
NCT00762983
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +16 more
- Locations
-
Not specified
NCT02238249
- Conditions
- Hypersensitivity, Hypersensitivity, Immediate, Immune System Diseases, +4 more
- Locations
-
Not specified